Search research articles
Contact Us
Filters
Showing results (231-240 of 504) with videos related to
Page
of 51
Sort By:
Diabetes Care
|
November 30, 2017
Comparison of β-Cell Function Between Overweight/Obese Adults and Adolescents Across the Spectrum of Glycemia
Melinda E Chen, Aaditya G Chandramouli, Robert V Considine, et al.
Cell Biophysics
|
August 1, 1992
Radiolabeled octreotide. What lessons for antibody-mediated targeting?
S J Mather, E Ur, J Bomanji, et al.
Heart Failure Reviews
|
March 30, 2007
Renal dysfunction in heart failure patients: what is the evidence?
Heath E Saltzman, Kumar Sharma, Paul J Mather, et al.
Diabetes/Metabolism Research and Reviews
|
May 14, 2014
Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP)
Tamara S Hannon, M S Kirkman, Yash R Patel, et al.
Medicine and Science in Sports and Exercise
|
August 20, 2014
Effect of prolonged sitting and breaks in sitting time on endothelial function
Saurabh S Thosar, Sylvanna L Bielko, Kieren J Mather, et al.
The Journal of Pediatrics
|
April 1, 1988
Prevalence of giardiasis in patients with cystic fibrosis
D M Roberts, J C Craft, F J Mather, et al.
Journal of Medicinal Chemistry
|
February 24, 2007
Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling
M Bashir-Uddin Surfraz, Robert King, Stephen J Mather, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 1, 1996
Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice
K A Coerver, T K Woodruff, M J Finegold, et al.
Journal of Medicinal Chemistry
|
July 14, 2009
Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation
Elisabeth von Guggenberg, Werner Sallegger, Anna Helbok, et al.
Nuclear Medicine Communications
|
July 1, 1992
A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)
K K Solanki, J Bomanji, J Moyes, et al.
Page
of 51
Search research articles
Search
Showing results (231-240 of 504) with videos related to
Sort By:
Page
of 51
Diabetes Care
|
November 30, 2017
Comparison of β-Cell Function Between Overweight/Obese Adults and Adolescents Across the Spectrum of Glycemia
Melinda E Chen, Aaditya G Chandramouli, Robert V Considine, et al.
Cell Biophysics
|
August 1, 1992
Radiolabeled octreotide. What lessons for antibody-mediated targeting?
S J Mather, E Ur, J Bomanji, et al.
Heart Failure Reviews
|
March 30, 2007
Renal dysfunction in heart failure patients: what is the evidence?
Heath E Saltzman, Kumar Sharma, Paul J Mather, et al.
Diabetes/Metabolism Research and Reviews
|
May 14, 2014
Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP)
Tamara S Hannon, M S Kirkman, Yash R Patel, et al.
Medicine and Science in Sports and Exercise
|
August 20, 2014
Effect of prolonged sitting and breaks in sitting time on endothelial function
Saurabh S Thosar, Sylvanna L Bielko, Kieren J Mather, et al.
The Journal of Pediatrics
|
April 1, 1988
Prevalence of giardiasis in patients with cystic fibrosis
D M Roberts, J C Craft, F J Mather, et al.
Journal of Medicinal Chemistry
|
February 24, 2007
Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling
M Bashir-Uddin Surfraz, Robert King, Stephen J Mather, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 1, 1996
Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice
K A Coerver, T K Woodruff, M J Finegold, et al.
Journal of Medicinal Chemistry
|
July 14, 2009
Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation
Elisabeth von Guggenberg, Werner Sallegger, Anna Helbok, et al.
Nuclear Medicine Communications
|
July 1, 1992
A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)
K K Solanki, J Bomanji, J Moyes, et al.
Page
of 51